Evidence map›Paper›PMID 32668608›Full record

ArticleCells2020

Molecular Protein and Expression Profile in the Primary Tumors of Clear Cell Renal Carcinoma and Metastases.

Liudmila V Spirina, Zahar A Yurmazov, Alexey K Gorbunov, Evgeny A Usynin, Nadezhda A Lushnikova, Irina V Kovaleva

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Liudmila V SpirinaCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634050, Russia.ORCID 0000-0002-5269-736X
Zahar A YurmazovCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634050, Russia.
Alexey K GorbunovCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634050, Russia.
Evgeny A UsyninCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634050, Russia.
Nadezhda A LushnikovaCancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634050, Russia.
Irina V KovalevaSiberian State Medical University, Tomsk 634050, Russia.
Russian Academy of Sciences · RUSiberian State Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastasis involves the spread of cancer cells from the primary tumor to surrounding tissues and distant organs and is the primary cause of cancer morbidity and mortality. The aim of the study was the determination of change in molecular factors expression in primary kidney cancers (ccRCC) and metastatic sites. In total, 62 patients with RCC were enrolled in the study. The mRNA levels of molecular markers were studied by real-time PCR, and the content of the studied parameters was determined by Western blotting and ELISA. The features in the intracellular signal metabolites in the series of normal renal parenchyma, tumor tissue of localized, disseminated kidney cancer and metastatic tissue were studied. A decrease in some indicators in the tissue of the metastatic lesion was noted. Protein products of transcription factors HIF-1, CAIX, PTEN and activated AKT kinase, as well as expression of the VEGFR2 receptor and m-TOR protein kinase were revealed to be reduced in the metastatic sites. In addition, some indicators increased in metastasis: the protein levels of NF-κB p 50, NF-κB p 65, HIF-2, VEGF, VEGFR2, m-TOR and mRNA of HIF-1, CAIX, PTEN and PDK. There were indicators with multidirectional changes. HIF-1, CAIX, PTEN, VEGFR2 and m-TOR mRNA: VEGFR2, m-TOR, HIF-1, CAIX, PTEN and PDK had an opposite change in protein content and mRNA level. PTEN loss resulted in the downstream activation of AKT/mTOR signaling in secondary cancer lesions and determined the overall ccRCC patient's survival. The AKT/mTOR signaling cascade activation was found in the primary kidney tumors. The PTEN content and mRNA level were correlated with total AKT, GSK-3β, the 70S 6 kinases and AKT expression.

Indexed as

Carcinoma, Renal CellFemaleGene Expression Regulation, NeoplasticHumansKidney NeoplasmsMaleMiddle AgedModels, BiologicalNeoplasm MetastasisNeoplasm ProteinsRNA, MessengerNeoplasm ProteinsRNA, MessengerAKT/mTOR componentsgrowth factorskidney cancersmetastatic sitesprimary tumorsPTENtranscription factors

Identifiers

PMID32668608
PMCPMC7408457
OpenAlexW3041253882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.